Europe — EMA

Ondansetron Tenshi Kaizen

Ondondansetron, the active ingredient in Ondansetron Tenshi Kaizen, is a 5-HT3 receptor antagonist presented as a unknown/unknown for oral use.

Ondansetron

Request sourcing

Pack/s

What is Ondansetron?

Ondondansetron, the active ingredient in Ondansetron Tenshi Kaizen, is a 5-HT3 receptor antagonist presented as a unknown/unknown for oral use. It treats and prevents nausea and vomiting associated with chemotherapy, radiation therapy, and postoperative recovery in adults and children. GNH USA supplies Ondansetron Tenshi Kaizen as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, pharmacies and clinics worldwide.

GNH USA supplies Ondansetron Tenshi Kaizen as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals oncology centres pharmacies and clinics worldwide.

What is Ondansetron used for?

Ondansetron is a selective 5‑HT3 receptor antagonist used in the management of nausea and vomiting pathways.

- Chemotherapy‑induced nausea and vomiting: Reduces the frequency and severity of CINV. - Post‑operative post‑Surgery vomiting: Helps de‑ de‑ de de de de. - Radiation radi radi radi radi radi radi radi radi radi radi radi radi radi radi radi t . - t. - . - . - . - . - . - . - . - . - . - . - . - t. - .

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →